ASX Releases
To access ASX releases prior to those listed below please visit the ASX Website and enter our ASX Code BTA.
2007
- ASX Appendix 3B: New Issue Announcement 24 December 2007
- ASX Appendix 3Y: Directors' Interest - I Gust 19 December 2007
- Court directs mediation by 16 May 2008 17 December 2007
- LANI Phase II clinical trials commence 22 November 2007
- ASX Appendix 3Y: Directors' Interest - I Gust 13 November 2007
- Substantial Shareholder Notice 8 November 2007
- ASX Appendix 3Y: Directors' Interest - J Grant 7 November 2007
- Substantial Shareholder Notice 7 November 2007
- Relenza Q1 Royalty delivers $4.5m 25 October 2007
- Appendix 3B: New Issue Announcement 24 October 2007
- 2007 Annual General Meeting Results 24 October 2007
- 2007 Annual General Meeting Addresses 24 October 2007
- Substantial Shareholder Notice 23 October 2007
- Substantial Shareholder Notice 12 October 2007
- Substantial Shareholder Notice 1 October 2007
- Substantial Shareholder Notice 21 September 2007
- Notice of Annual General Meeting 12 September 2007
- ASX Appendix 3B: New Issue Announcement 30 August 2007
- 2007 Annual Report 29 August 2007
- 2007 Concise Annual Report 29 August 2007
- Open Briefing - CEO on FY07 Results & Outlook 10 August 2007
- Biota delivers Profit after tax of $20.2m 9 August 2007
- Preliminary Final Report 9 August 2007
- ASX Appendix 3B: New Issue Announcement 9 August 2007
- Substantial Shareholder Notice 9 August 2007
- ASX Appendix 3B: New Issue Announcement 1 August 2007
- Biota raises Relenza claim to $A564 - A$704 millio 31 July 2007
- Substantial Shareholder Notice 30 July 2007
- $11.1m in Quarterly Royalties from Relenza 26 July 2007
- RSV Drug Starts Phase Ia Clinical Trials 17 July 2007
- Biota Acquires VCP Relenza Royalty 2 July 2007
- Lapsed Options 29 June 2007
- ASX Appendix 3Y: Directors' Interest - I Gust 8 June 2007
- ASX Appendix 3B: New Issue Announcement 7 June 2007
- Full Year Profit Guidance 31 May 2007
- Biota Acquires CSIRO Relenza Royalty 3 May 2007
- ASX Appendix 3B: New Issue to CSIRO 3 May 2007
- Q3 Relenza Royalties grow to $16m 26 April 2007
- LANI Phase I complete in Japan-commencing in UK 19 April 2007
- Substantial Shareholder Notice 2 April 2007
- Biota Details GSK's Failures to Support Relenza 29 March 2007
- ASX Appendix 3B: New Issue Announcement 28 March 2007
- HRV drug successful in Phase I 26 March 2007
- ASX Appendix 3Y: Directors' Interest - B Gibson 8 March 2007
- ASX Appendix 3Y: Directors' Interest - G Latta 6 March 2007
- ASX Appendix 3Y: Directors' Interest - P Cook 1 March 2007
- ASX Appendix 3Y: Directors' Interest - I Gust 27 February 2007
- ASX Appendix 3Y: Directors' Interest - J Grant 27 February 2007
- Top Twenty Shareholders 26 February 2007
- Open Briefing - CEO on Half Year Profit 21 February 2007
- Half Year Report & Accounts 21 February 2007
- Substantial Shareholder Notice 19 February 2007
- Q2 Royalties from Relenza grow to $7.3m 9 February 2007
- ASX Appendix 3Y: Directors' Interest - P Bell 12 January 2007
